Aug 3, 2020
Silencing the SARS-CoV-2 Receptor With CRISPR and Epigenetic Modifications
Posted by Lon Anderson in categories: biotech/medical, genetics
The Hackett Group at EMBL Rome explores epigenetics, genome regulation and cell identity. Recently, the scientists developed a novel CRISPR molecular tool for editing the epigenome, enabling transient modifications that can switch certain genes “on” and “off” temporarily.
The SARS-CoV-2 virus that has caused the COVID-19 global pandemic makes its way into a host cell via a protein known as ACE2, which is involved in a range of physiological functions in the body.
Continue reading “Silencing the SARS-CoV-2 Receptor With CRISPR and Epigenetic Modifications” »